• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白90(Hsp90)N端结构域肽抑制剂的双位点靶向:机制与设计

Dual-Site Targeting by Peptide Inhibitors of the N-Terminal Domain of Hsp90: Mechanism and Design.

作者信息

Zang Min, Gan Haipeng, Zhou Xuejie, Wang Lei, Dong Hao

机构信息

Kuang Yaming Honors School, Nanjing University, Nanjing 210023, China.

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

出版信息

J Chem Inf Model. 2025 May 26;65(10):5113-5123. doi: 10.1021/acs.jcim.5c00629. Epub 2025 May 1.

DOI:10.1021/acs.jcim.5c00629
PMID:40310892
Abstract

Heat shock protein 90 (Hsp90) is a pivotal molecular chaperone crucial in the maturation of client proteins, positioning it as a significant target for cancer therapy. However, the design of effective Hsp90 inhibitors presents substantial challenges due to the complex interaction network and the requisite specificity of the inhibitors. This study tackles the task of designing peptide inhibitors capable of concurrently binding to both the ATP-binding pocket and the Cdc37-binding site within the N-terminal domain of Hsp90. In response to these challenges, we developed an advanced peptide screening protocol that merges machine learning with various molecular simulation techniques to boost the identification and optimization of potent inhibitors. Our integrated approach employs a convolutional neural network-based framework to predict peptide binding propensities. This predictive model is augmented by comprehensive molecular docking and dynamic simulations to assess the stability and interaction dynamics of Hsp90/peptide complexes. We successfully identified three heptapeptides that demonstrate the ability to interact with both binding sites, effectively obstructing the entrance to the ATP-binding pocket. This study elucidates the inhibitory mechanisms of these peptides, paves the way for the development of more efficacious therapeutic agents targeting Hsp90, and underscores the value of integrating machine learning techniques with molecular modeling in the peptide design process.

摘要

热休克蛋白90(Hsp90)是一种关键的分子伴侣,对客户蛋白的成熟至关重要,这使其成为癌症治疗的重要靶点。然而,由于复杂的相互作用网络以及抑制剂所需的特异性,设计有效的Hsp90抑制剂面临重大挑战。本研究致力于设计能够同时结合Hsp90 N端结构域内ATP结合口袋和Cdc37结合位点的肽抑制剂。针对这些挑战,我们开发了一种先进的肽筛选方案,该方案将机器学习与各种分子模拟技术相结合,以促进强效抑制剂的识别和优化。我们的综合方法采用基于卷积神经网络的框架来预测肽的结合倾向。通过全面的分子对接和动力学模拟对该预测模型进行增强,以评估Hsp90/肽复合物的稳定性和相互作用动力学。我们成功鉴定出三种七肽,它们能够与两个结合位点相互作用,有效阻碍ATP结合口袋的入口。本研究阐明了这些肽的抑制机制,为开发更有效的靶向Hsp90的治疗药物铺平了道路,并强调了在肽设计过程中将机器学习技术与分子建模相结合的价值。

相似文献

1
Dual-Site Targeting by Peptide Inhibitors of the N-Terminal Domain of Hsp90: Mechanism and Design.热休克蛋白90(Hsp90)N端结构域肽抑制剂的双位点靶向:机制与设计
J Chem Inf Model. 2025 May 26;65(10):5113-5123. doi: 10.1021/acs.jcim.5c00629. Epub 2025 May 1.
2
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling.可视化蛋白质折叠机制的动态:Hsp90 中不对称 ATP 处理的机制及其对客户重塑的影响。
J Mol Biol. 2021 Jan 22;433(2):166728. doi: 10.1016/j.jmb.2020.166728. Epub 2020 Dec 1.
3
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.新生霉素及Hsp90 C端核苷酸结合口袋的其他抑制剂。
Curr Med Chem. 2008;15(26):2702-17. doi: 10.2174/092986708786242895.
4
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.源自C端肽螺旋的热休克蛋白90潜在C端结构域抑制剂。
Bioorg Med Chem. 2014 Aug 1;22(15):3989-93. doi: 10.1016/j.bmc.2014.06.006. Epub 2014 Jun 14.
5
Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.热休克蛋白 90(Hsp90)/细胞分裂周期蛋白 37(Cdc37)伴侣蛋白/共伴侣蛋白复合物,通过草药药物 Withaferin A 的作用模式阐明的新型连接点抗癌靶标。
BMC Bioinformatics. 2011 Feb 15;12 Suppl 1(Suppl 1):S30. doi: 10.1186/1471-2105-12-S1-S30.
6
Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain.基于结构整体的对接模拟和生物物理研究发现了 HSP90N 端结构域的新抑制剂。
Sci Rep. 2018 Jan 10;8(1):368. doi: 10.1038/s41598-017-18332-8.
7
Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.热休克蛋白90(Hsp90)-细胞周期蛋白依赖性激酶37(Cdc37)伴侣蛋白与细胞周期蛋白依赖性激酶4(Cdk4)客户蛋白结合的原子模拟和基于网络的建模:通过利用内在动态激酶结构域的弱点来陪伴激酶客户的机制
PLoS One. 2017 Dec 21;12(12):e0190267. doi: 10.1371/journal.pone.0190267. eCollection 2017.
8
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.美国食品药品监督管理局(FDA)批准的抗HIV蛋白酶抑制剂会成为有前景的抗癌药物吗?基于增强对接方法和分子动力学分析的解答。
Drug Des Devel Ther. 2015 Nov 13;9:6055-65. doi: 10.2147/DDDT.S87653. eCollection 2015.
9
Optimization and bioevaluation of Cdc37-derived peptides: An insight into Hsp90-Cdc37 protein-protein interaction modulators.Cdc37衍生肽的优化与生物评价:深入了解Hsp90-Cdc37蛋白-蛋白相互作用调节剂
Bioorg Med Chem. 2017 Jan 1;25(1):233-240. doi: 10.1016/j.bmc.2016.10.028. Epub 2016 Oct 27.
10
In silico identification and analysis of the binding site for aminocoumarin type inhibitors in the C-terminal domain of Hsp90.在 Hsp90 的 C 末端结构域中氨基香豆素类抑制剂结合位点的计算机识别与分析。
J Mol Graph Model. 2018 Sep;84:215-235. doi: 10.1016/j.jmgm.2018.06.016. Epub 2018 Jun 21.

引用本文的文献

1
Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.癌症治疗中HSP90抑制剂的联合策略:作用机制、挑战与未来展望
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1083. doi: 10.3390/ph18081083.